Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 - Marketscreener.com
| NXEN Stock | USD 0.01 0.01 25.00% |
About 59% of Nexien Biopharma's investor base is looking to short. The analysis of overall sentiment of trading Nexien Biopharma pink sheet suggests that many investors are alarmed at this time. Nexien Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Nexien Biopharma. Many technical investors use Nexien Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Nexien |
Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 Marketscreener.com
Read at news.google.com
 |
Nexien Biopharma Fundamental Analysis
We analyze Nexien Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexien Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexien Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Nexien Biopharma is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Peers
Trending Equities
Other Information on Investing in Nexien Pink Sheet
Nexien Biopharma financial ratios help investors to determine whether Nexien Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nexien with respect to the benefits of owning Nexien Biopharma security.